Biotech Series A Investors & VC Firms
1596 firms in this list, with a median first check of $500K. 341 of them lead rounds. Generated from verified public data and updated continuously.
Liebenthal Ventures
Old WestburyPre-Seed–Series A$25K – $500K
1 person
20/20 HealthCare Partners LLC
AuburndaleSeed–Late Stage
7 people
Angelini Ventures
RomeSeed–Growth
4 people
GLOCAL Latam
RosarioPre-Seed–Growth$500K
7 people
ACVC Partners
Silicon ValleyPre-Seed–Series A
6 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
Hike Capital
BeijingPre-Seed–Late Stage
6 people
InnoCom Bio Equities
San FranciscoPre-Seed–Series A
9 people
Ming capital
ShenzhenSeed–Late Stage
6 people
Ontario Centre of Innovation programs
TorontoPre-Seed–Growth
3 people
Red Bear Angels
IthacaSeed–Series A$100K – $1M
3 people
SciFounders
San FranciscoPre-Seed–Series A$1M
3 people
Black Diamond Ventures
GlendalePre-Seed–Late Stage$2M – $10M
8 people
FusionX Ventures
San DiegoPre-Seed–Series A
8 people
NYBC Ventures
New YorkSeed–Series B
8 people
Helios Capital
MiamiPre-Seed–Series A$25K – $1M
1 person
Accelerate Fund
CalgaryPre-Seed–Series A$250K
4 people
Avestria Ventures
San FranciscoPre-Seed–Late Stage
4 people
Berkeley Catalyst
BerkeleySeed–Series A
4 people
CapMan
HelsinkiSeries A–Late Stage$2.2M – $64.8M
4 people
Checkmate Capital Group LLC
PasadenaSeed–Late Stage
7 people
Louisiana Funds
Baton RougePre-Seed–Series A
4 people
University of Cambridge Enterprise
CambridgePre-Seed–Late Stage
10 people
Anthropy Partners
SeattleSeed–Series A
6 people
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)SaaS Series A Investors & VC Firms (2667)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Healthtech Series A Investors & VC Firms (2210)Series A Investors & VC Firms in Global (2163)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)
Data sourced from public filings and firms' own websites — see our methodology.


























































